ABSTRACT

Background: Hridroga in Ayurveda encompasses various cardiovascular disorders, including conditions comparable to coronary artery disease (CAD). Rasayana therapy, which focuses on tissue rejuvenation and systemic strengthening, is significant in both preventive and therapeutic contexts. Shiva Gutika is a classical Ayurvedic formulation known for its Rasayana and Hridya (cardiotonic) effects. Objectives:To identify the therapeutical potential of Shiva Gutika tablet as a Rasayana for the management of Hridroga, as a secondary preventive measure in Coronary Artery Disease. Method: Literature review was done based on reviewing Ayurvedic texts, research articles, and various journals. The pharmacological aspects of Shiva Gutika tablet, like rasa (taste), guna (qualities), veerya (potency), and vipaka (post-digestive effect) was analyzed. Their effects on Agni, Srotas, and Saptadhatus were checked to understand their Rasayana potential in cardiovascular disorders. Results: The ingredients of Shiva Gutika demonstrate actions that regulate Agni, nourish Dhatus, and promote unobstructed flow in Srotas, particularly Raktavaha and Manovaha Srotas. It has Hridya, Balya action, Rasayana, and Medhya properties which contributes to enhance cardiac functioning. The effects observed helps in suggesting role of Shiva Gutika in delaying CAD progression and help in improvement of overall heart. Conclusion: Shiva Gutika Rasayana can be a potent secondary preventive measure in the management of CAD Keywords: Coronary Artery Disease, Hridroga, Rasayana, rasapanchaka, Antioxidant
Publication date: 01/08/2026

https://www.ijbpas.com/pdf/2026/August/MS_IJBPAS_2026_10291.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2026/15.8.10291